| -0.21 / -1.67%|
The 7 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 10.00. The median estimate represents a +61.94% increase from the last price of 12.35.
The current consensus among 7 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.